MedPath

Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma

Conditions
Classical Hodgkin Lymphoma
Registration Number
NCT02808520
Lead Sponsor
Martin-Luther-Universität Halle-Wittenberg
Brief Summary

Purpose of this study is to determine the influence of social factors on participation and activity among children and adolescents aged 10-18 years with hodgkin-lymphoma. Furthermore personal and treatment-related factors and their impact on participation will be explored.

Detailed Description

Hodgkin-lymphoma is a rare malignancy among children and adolescents (about 140 each year in Germany) which is highly curable. Beside this therapeutic success, a lot of therapy-related long-term problems arise (e.g. fertility disorders, thyroid diseases, secondary malignancies). While most of the studies focused on mental and physical impairments, little attention has been drawn to social dimensions of health. Due to the disease and the requirements of the therapy, participation of children with hodgkin-lymphoma can be impaired acutely or chronically. This can be of serious consequences, because participation in daily life is an important component of the development of children and adolescents. To determine the influence of social, personal and treatment-related factors on participation, all patients who were actual treated in the international therapy study EuroNet-PHL-C2 in all of Germany (N ≈ 700) and their parents will be interviewed. Statistical analyses will be done using descriptive and multivariate methods taking account of treatment-related issues (e.g. stage of disease, chemotherapy, radiotherapy, progression/relapse).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
700
Inclusion Criteria
  • histologically confirmed primary diagnosis of classical Hodgkin's Lymphoma
  • 10-18 years
  • written informed consent of the patient and/or the patient's parents or guardian according to national laws
Read More
Exclusion Criteria
  • other (simultaneous) malignancies
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Social participationone month after diagnosis until two years

The Child and Adolescent Scale of Participation, CASP

Quality of lifeone month after diagnosis until two years

Questionnaire to assess Health Related Quality of Life in chronically ill Children and Adolescents, KINDL

Secondary Outcome Measures
NameTimeMethod
Autonomyone month after diagnosis until two years

Subscale Autonomy from the Health-Related Quality of Life Questionnaire for Children and Adolescents, Kidscreen

Understanding of illnessone month after diagnosis until two years

Illness Perception Questionnaire, IPQ

Satisfaction with treatmentone month after diagnosis until two years

Questionnaire to assess the Satisfaction with the Treatment, FBB

Social supportone month after diagnosis until two years

Social Support Scale, SSS

Self-efficacyone month after diagnosis until two years

Self-Efficacy for Managing Chronic Disease 6-Item Scale, SES6

Optimismone month after diagnosis until two years

Subscale from The Bern Subjective Well-Being Questionnaire for Adolescents, BFW

Copingone month after diagnosis until two years

Coping Questionnaire for Children and Adolescents, CODI

Sense of coherenceone month after diagnosis until two years

Children Sense of Coherence Scale, C-SOC

Behavioural disorders and strengthsone month after diagnosis until two years

Strengths and Difficulties Questionnaire, SDQ

Fatigueone month after diagnosis until two years

Subscale Fatigue from the Questionnaire to assess Quality of Life of Cancer Patients developed by the European Organisation for Research and Treatment of Cancer, EORTC QLQ-C30

© Copyright 2025. All Rights Reserved by MedPath